APOA1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, participants in Q1 of the HDL-C/ApoA-I index had a higher prevalence of excess adipose tissue, NAFLD, dyslipidemia, MS, and HOMA-IR compared with subjects with upper quartiles (Fig. 1).